SUPERNEWS

Equities

JPMorgan's Focus List Adds New Stocks for Growth and Income Opportunities

JPMorgan Refreshes Focus List with REITs and Pharma Picks, Eyeing Growth and Income Opportunities

By Bill Bullington

ᐧ

3/4, 06:32 EST
article-main-img

Key Takeaway

  • JPMorgan adds Annaly Capital and EPR Properties for income, with price targets suggesting up to 22% upside, and Ascendis Pharma for growth, targeting an 8% rise.
  • The bank's focus list spans growth, income, value, and short strategies across various sectors including REITs and pharmaceuticals.
  • Other top picks include major names like Caterpillar, Danaher, Amazon, Broadcom, and Eli Lilly for diversified investment opportunities.

JPMorgan's Top Stock Picks

JPMorgan recently updated its focus list with three new stocks, including two real estate investment trusts (REITs) and a pharmaceutical company. The bank's focus list covers top equity ideas across growth, income, value, and short strategies. Here are the key highlights from JPMorgan's latest picks:

Annaly Capital and EPR Properties

  • JPMorgan added Annaly Capital and EPR Properties to its focus list as income ideas.
  • Annaly Capital, specializing in residential mortgage finance, offers a compelling double-digit yield with book value upside.
  • EPR Properties, with properties including ski resorts and movie theaters, boasts an above-average monthly dividend and improving growth opportunities.
  • Annaly Capital's $20 price target implies a nearly 4% rise, while EPR Properties could see a 22% upside based on JPMorgan's $51 price target.

Ascendis Pharma

  • Ascendis Pharma, a pharmaceutical company, was added as a growth play.
  • The company's upcoming launches, cost containment efforts, and potential GLP-1 drug licensing deal were cited as catalysts.
  • JPMorgan set a $165 price target for Ascendis Pharma, more than 8% above its closing price.

Other Top Picks

  • JPMorgan's focus list also includes other top picks like Caterpillar, Danaher, Amazon, Broadcom, and Eli Lilly.
  • These picks cover a range of strategies and market caps, offering investors a diversified selection of investment opportunities.

Street Views

  • Richard Shane, JPMorgan (Bullish on Annaly Capital):

    "Compelling double digit yield with book value upside from lower rates and tighter MBS spreads."

  • Anthony Paolone, JPMorgan (Bullish on EPR Properties):

    "Properties in the company’s portfolio include ski resorts, amusement parks and movie theaters... above-average monthly dividend as a catalyst, alongside improving growth opportunities that could drive its price higher."

  • Jessica Fye, JPMorgan (Bullish on Ascendis Pharma):

    "The bank has a $165 price target... As catalysts for the addition, analyst Jessica Fye cited the company’s upcoming launches, cost containment efforts and the potential for a GLP-1 drug licensing deal."